Industry Insights

  1. Dry Powdered Medium Milling Equivalency Study 9/26/2022

    An assessment of the physical, chemical, and biological characteristics of representative complex media and feeds was made to compare pin mills and overall dry powdered medium manufacturing processes.

  2. AI Data Security: The 83% Compliance Gap Facing Pharmaceutical Companies 7/23/2025

    A new study reveals a shocking truth: only 17% of pharmaceutical companies — including many CDMOs — have implemented automated controls to prevent sensitive data from leaking through AI tools.

  3. Fermentation Of Live Biotherapeutic Products In cGMP Environments 10/8/2025

    We follow the journey from master cell bank to large-scale anaerobic fermentation, highlighting the unique needs for working with oxygen-sensitive, strictly anaerobic therapeutic microbes in a cGMP setting. 

  4. Development And Manufacture Of A Highly Potent OSD Product 10/20/2025

    Highly potent drug compounds require advanced containment and robust technical transfer protocols. CDMOs overcome challenges through meticulous testing, specialized tooling, and strong supplier relationships.

  5. Which Microscope Camera Is Right for You? 1/5/2024

    What are the key factors to consider when choosing the right microscope camera for your system and experimental needs?

  6. The 4 Technologies Poised To Transform The Pharmaceutical Supply Chain In 2025 And Beyond 12/2/2024

    These key technological advancements will significantly impact the pharma/biotech supply chain in 2025 and beyond. If you aren't implementing any of them yet, you may want to rethink your plans.

  7. Streamline Early Clinical Development With An INTERACT Meeting 3/9/2020

    Read how the INTERACT meeting can be an invaluable engagement with the agency to inform the successful planning and execution of a novel product development program.

  8. Microbial Expression System For Efficient Production Of Therapeutic Proteins

    The combination of unique and proven plasmids, fast process development, and automated downstream analysis ensures rapid progression from gene to optimized, high-titer fermentation process.

  9. 4 Risk Mitigation Strategies For mRNA Production 4/17/2023

    Planning and procuring custom materials needed to manufacture mRNA remains a top concern. This article shares risk mitigation strategies for multi-sourcing, S&OP process, packaging size, and material expiry.

  10. Exploring The Challenges Of Cell Dissociation In Vaccine Manufacturing 6/9/2025

    Vaccine manufacturing relies on efficient cell dissociation methods. Explore the challenges of traditional approaches like trypsin and the benefits of animal origin-free alternatives for improved workflows.